Study says US drug companies spend more on promotion

A study by two Canadian researchers says US drug companies spend nearly twice as much on promoting their products ($57.5 billion in 2004) than they spend on research and development ($31.5 billion in 2004). PhRMA called the contention a “myth.”

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions